2022 Q1 Form 10-K Financial Statement

#000095017022004418 Filed on March 23, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021
Revenue $9.033M $9.891M $33.20M
YoY Change 21.62% -57.64% 42.17%
Cost Of Revenue $6.754M $7.439M $24.86M
YoY Change 18.8% -61.78% 27.71%
Gross Profit $2.279M $2.452M $8.336M
YoY Change 30.83% -36.89% 114.57%
Gross Profit Margin 25.23% 24.79% 25.11%
Selling, General & Admin $11.99M $11.31M $33.91M
YoY Change 83.71% -57.62% 27.04%
% of Gross Profit 525.89% 461.38% 406.83%
Research & Development $4.850M $4.258M $18.57M
YoY Change -3.88% -79.19% -9.25%
% of Gross Profit 212.81% 173.65% 222.74%
Depreciation & Amortization $246.0K $483.0K $1.426M
YoY Change -39.11% -71.64% -31.41%
% of Gross Profit 10.79% 19.7% 17.11%
Operating Expenses $16.84M $16.02M $52.74M
YoY Change 45.33% -65.68% 12.98%
Operating Profit -$14.56M -$13.57M -$44.41M
YoY Change 47.9% -68.3% 3.76%
Interest Expense -$966.0K -$388.0K -$4.162M
YoY Change -90.79% -1.16%
% of Operating Profit
Other Income/Expense, Net $247.0K $71.00K
YoY Change -28.61% -79.48%
Pretax Income -$15.52M -$13.71M -$48.50M
YoY Change 42.33% -70.62% 3.93%
Income Tax $0.00 $2.000K $2.000K
% Of Pretax Income
Net Earnings -$15.52M -$13.71M -$48.50M
YoY Change 42.33% -70.62% 3.93%
Net Earnings / Revenue -171.84% -138.62% -146.09%
Basic Earnings Per Share -$0.59 -$8.52
Diluted Earnings Per Share -$587.8K -$520.0K -$1.842M
COMMON SHARES
Basic Shares Outstanding 26.40M 26.33M 5.695M
Diluted Shares Outstanding 26.41M 5.695M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $66.05M $84.64M $84.64M
YoY Change 63.65%
Cash & Equivalents $66.10M $84.64M $84.64M
Short-Term Investments
Other Short-Term Assets $3.968M $3.552M $3.552M
YoY Change 294.23%
Inventory $10.13M $8.150M $8.150M
Prepaid Expenses
Receivables $2.702M $2.516M $2.516M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $82.86M $98.86M $98.86M
YoY Change 67.86% 67.86%
LONG-TERM ASSETS
Property, Plant & Equipment $2.177M $2.366M $5.112M
YoY Change -24.96% -20.88%
Goodwill $8.454M $8.454M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $118.0K $118.0K $118.0K
YoY Change -4.07% -4.07%
Total Long-Term Assets $16.02M $16.64M $16.64M
YoY Change -3.51% -3.51%
TOTAL ASSETS
Total Short-Term Assets $82.86M $98.86M $98.86M
Total Long-Term Assets $16.02M $16.64M $16.64M
Total Assets $98.88M $115.5M $115.5M
YoY Change 51.69% 51.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.235M $3.061M $3.061M
YoY Change 58.6% 58.6%
Accrued Expenses $4.416M $4.758M $9.109M
YoY Change 46.54% 17.34%
Deferred Revenue $747.0K $771.0K
YoY Change -8.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $55.00K
YoY Change
Total Short-Term Liabilities $12.09M $14.65M $14.65M
YoY Change -64.09% -64.09%
LONG-TERM LIABILITIES
Long-Term Debt $26.62M $26.50M $26.57M
YoY Change
Other Long-Term Liabilities $517.0K $558.0K $2.218M
YoY Change -28.09% -71.88%
Total Long-Term Liabilities $27.14M $27.05M $28.78M
YoY Change 3386.34% 264.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.09M $14.65M $14.65M
Total Long-Term Liabilities $27.14M $27.05M $28.78M
Total Liabilities $40.70M $43.44M $43.44M
YoY Change -10.79% -10.79%
SHAREHOLDERS EQUITY
Retained Earnings -$327.6M -$312.0M
YoY Change 18.4%
Common Stock $385.8M $384.2M
YoY Change 3858.35%
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K $51.00K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $58.18M $72.06M $72.06M
YoY Change
Total Liabilities & Shareholders Equity $98.88M $115.5M $115.5M
YoY Change 51.69% 51.69%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021
OPERATING ACTIVITIES
Net Income -$15.52M -$13.71M -$48.50M
YoY Change 42.33% -70.62% 3.93%
Depreciation, Depletion And Amortization $246.0K $483.0K $1.426M
YoY Change -39.11% -71.64% -31.41%
Cash From Operating Activities -$31.50M -$14.72M -$48.60M
YoY Change 141.07% -2.38% 26.09%
INVESTING ACTIVITIES
Capital Expenditures $56.00K -$191.0K $638.0K
YoY Change -24.32% -65.71% -30.35%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$56.00K -$191.0K -$1.973M
YoY Change -24.32% -65.71% 115.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $84.39M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -486.0K 85.81M 83.50M
YoY Change -24.65% -1716280.0% -8594.1%
NET CHANGE
Cash From Operating Activities -31.50M -14.72M -48.60M
Cash From Investing Activities -56.00K -191.0K -1.973M
Cash From Financing Activities -486.0K 85.81M 83.50M
Net Change In Cash -18.59M 70.89M 32.92M
YoY Change 34.83% -553.11% -181.4%
FREE CASH FLOW
Cash From Operating Activities -$31.50M -$14.72M -$48.60M
Capital Expenditures $56.00K -$191.0K $638.0K
Free Cash Flow -$31.56M -$14.53M -$49.24M
YoY Change 140.13% 0.05% 24.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001407973
CY2021Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5479
CY2020Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-40988
CY2021 dei Entity Registrant Name
EntityRegistrantName
Sonendo, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5041718
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
26061 Merit Circle
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 102
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Laguna Hills
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92653
CY2021 dei City Area Code
CityAreaCode
949
CY2021 dei Local Phone Number
LocalPhoneNumber
766-3636
CY2021 dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
CY2021 dei Trading Symbol
TradingSymbol
SONX
CY2021 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Public Float
EntityPublicFloat
120400000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26395942
CY2020Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
388000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3308000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2956000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3061000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2208000
CY2021Q4 us-gaap Goodwill
Goodwill
8454000
CY2020Q4 us-gaap Goodwill
Goodwill
8454000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
118000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1930000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
123000
CY2021Q4 us-gaap Assets
Assets
115499000
CY2020Q4 us-gaap Assets
Assets
76141000
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1914000
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2021 dei Auditor Location
AuditorLocation
Irvine, California
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
84641000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51722000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2516000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1934000
CY2021Q4 us-gaap Inventory Net
InventoryNet
8150000
CY2020Q4 us-gaap Inventory Net
InventoryNet
4338000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3552000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
901000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
98859000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
58895000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2366000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3153000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2746000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4758000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3247000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3376000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3714000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
975000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
802000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
28352000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2482000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2756000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14652000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40801000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1730000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2449000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
26496000
CY2020Q4 sonx Forward Obligation Noncurrent
ForwardObligationNoncurrent
2750000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
558000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
776000
CY2021Q4 us-gaap Liabilities
Liabilities
43436000
CY2020Q4 us-gaap Liabilities
Liabilities
48690000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
281342000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21643836
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26336536
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1247024
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26289847
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1200335
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
26000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
384132000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
9703000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-312044000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-263545000
CY2021Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
72114000
CY2020Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
-253840000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
72063000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-253891000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115499000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76141000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33197000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23351000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24861000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19466000
CY2021 us-gaap Gross Profit
GrossProfit
8336000
CY2020 us-gaap Gross Profit
GrossProfit
3885000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33913000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
44000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1644000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26695000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18568000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20461000
CY2021 sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
261000
CY2020 sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
-473000
CY2021 us-gaap Operating Expenses
OperatingExpenses
52742000
CY2020 us-gaap Operating Expenses
OperatingExpenses
46683000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-44406000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-42798000
CY2021 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-4214000
CY2020 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-3961000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-71000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-346000
CY2021 sonx Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
52000
CY2020 sonx Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
-250000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48497000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46663000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-48499000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-46665000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-8.52
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-39.02
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5694594
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1195944
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-208914000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-46665000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-253891000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
281342000
CY2021 sonx Stock Issued During Period Value Settlement Of Outstanding Forward Obligation Into Common Stock On Initial Public Offering
StockIssuedDuringPeriodValueSettlementOfOutstandingForwardObligationIntoCommonStockOnInitialPublicOffering
2698000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
9800000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
83792000
CY2021 sonx Adjustments To Additional Paid In Capital Reclassification Of Convertible Preferred Stock Warrant Into Common Stock Warrant On Initial Public Offering
AdjustmentsToAdditionalPaidInCapitalReclassificationOfConvertiblePreferredStockWarrantIntoCommonStockWarrantOnInitialPublicOffering
3978000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
271000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2372000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-48499000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
72063000
CY2021 us-gaap Profit Loss
ProfitLoss
-48499000
CY2020 us-gaap Profit Loss
ProfitLoss
-46665000
CY2021 us-gaap Depreciation
Depreciation
1426000
CY2020 us-gaap Depreciation
Depreciation
2079000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
586000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
531000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
985000
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
957000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
558000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
638000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
916000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2372000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1644000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-71000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-346000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
778000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
807000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-2000
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-57000
CY2021 sonx Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
52000
CY2020 sonx Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
-250000
CY2021 sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
261000
CY2020 sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
-473000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
582000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-707000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3812000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2379000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2646000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-156000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1128000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-369000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-71000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1850000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-72000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
222000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-338000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1370000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48605000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38544000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1335000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1973000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-916000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
84390000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
271000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
44000
CY2021 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
667000
CY2020 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
987000
CY2020 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
5138000
CY2020 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
5138000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
47000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
40000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
450000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
83497000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-983000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32919000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-40443000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
51722000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
92165000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
84641000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
51722000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
2000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
3445000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3446000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
424000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3082000
CY2021 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
281342000
CY2021 sonx Settlement Of Outstanding Forward Obligation Into Common Stock On Initial Public Offering
SettlementOfOutstandingForwardObligationIntoCommonStockOnInitialPublicOffering
2698000
CY2021 sonx Reclassification Of Convertible Preferred Stock Warrant Into Common Stock Warrant On Initial Public Offering
ReclassificationOfConvertiblePreferredStockWarrantIntoCommonStockWarrantOnInitialPublicOffering
3978000
CY2021 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On October 20, 2021, the Company’s Board of Directors approved an amendment to the Company’s certificate of incorporation to effect a reverse split of shares of the Company’s common stock and convertible preferred stock on a 1-for-1.825 basis (the “Reverse Stock Split”). The par values of the common stock and convertible preferred stock were not adjusted as a result of the Reverse Stock Split.
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
84600000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-312000000.0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-48500000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48600000
CY2021 sonx Number Of Operating And Reportable Segments
NumberOfOperatingAndReportableSegments
2
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with GAAP requires management to make informed estimates, judgements and assumptions that affect the reported amounts in the consolidated financial statements and disclosures in the accompanying notes, including estimates of probable losses and expenses, as of the date of the accompanying consolidated financial statements. Management considers many factors in selecting appropriate financial accounting policies and in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including the expected business and operational changes, the sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Actual results could differ materially from the estimates and assumptions used in the preparation of the accompanying consolidated financial statements under different assumptions or conditions.</span></p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Concentration of Risks</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash, cash equivalents and accounts receivable. The Company has established guidelines to mitigate such potential risks by maintaining the Company’s cash balances with entities that management believes possess high credit quality to limit the amount of credit exposure. Substantially all of the Company’s cash and cash equivalents are maintained at one financial institution domiciled in the United States. Cash and cash equivalents can exceed amounts insured by the Federal Deposit Insurance Corporation of up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">250,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company has not experienced any losses in its accounts and management believes it is not exposed to any significant credit risk on cash and cash equivalents. The primary objectives of the Company’s investment portfolio are the preservation of capital and maintenance of liquidity.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company believes any concentration of credit risk in its accounts receivable is mitigated by its credit evaluation process, relatively short collection terms and the level of credit worthiness of its customers. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> individual customer accounted for more than 10% of sales or accounts receivable in 2021 or 2020.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company sources materials and services through several vendors. Certain materials are sourced from a single vendor. The loss of certain vendors could result in a temporary disruption of the Company’s commercialization efforts.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company’s products require clearance from the FDA and foreign regulatory agencies before commercial sales can commence. There can be no assurance that the Company’s products in development will receive any of these required clearances. The denial or delay of such clearances may have a material adverse impact on the Company’s business in the future. In addition, after the clearance by the FDA, there is still an ongoing risk of adverse events that did not appear during the device clearance process.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of its products, product liability and the need to obtain additional financing.</span></p>
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2021Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
771000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
843000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
5000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
771000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
838000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
800000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33197000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23351000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
300000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
300000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1584000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3447000
CY2021 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1515000
CY2020 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
996000
CY2021 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1479000
CY2020 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
2859000
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1620000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1584000
CY2021Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1132000
CY2020Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1202000
CY2021Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
488000
CY2020Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
382000
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1620000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1584000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
776000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
308000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 sonx Minimum Amount Tax Benefits Likely Of Being Realized Upon Settlement
MinimumAmountTaxBenefitsLikelyOfBeingRealizedUponSettlement
more than 50%
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4911000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2114000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
270000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2969000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1916000
CY2021Q4 us-gaap Inventory Net
InventoryNet
8150000
CY2020Q4 us-gaap Inventory Net
InventoryNet
4338000
CY2021Q4 sonx Inventory Reserves For Excess And Obsolete
InventoryReservesForExcessAndObsolete
700000
CY2020Q4 sonx Inventory Reserves For Excess And Obsolete
InventoryReservesForExcessAndObsolete
1100000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3380000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1172000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2208000
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
676000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2956000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11959000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11434000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9593000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8281000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2366000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3153000
CY2021 us-gaap Depreciation
Depreciation
1400000
CY2020 us-gaap Depreciation
Depreciation
2100000
CY2021 sonx Finite Lived Intangible Asset Weighted Average Amortization Period
FiniteLivedIntangibleAssetWeightedAverageAmortizationPeriod
P7Y7M6D
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4715000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1759000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2956000
CY2020 sonx Finite Lived Intangible Asset Weighted Average Amortization Period
FiniteLivedIntangibleAssetWeightedAverageAmortizationPeriod
P6Y8M12D
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
664000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
618000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
442000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
386000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
170000
CY2020Q4 sonx Vendor Invoices Current
VendorInvoicesCurrent
2232000
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1979000
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1015000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4758000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3247000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
17528207
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
17031887
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
331503
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
17031887
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
331503
CY2021Q4 sonx Vendor Invoices Current
VendorInvoicesCurrent
2779000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
55000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
47000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
524000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
667000
CY2021Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1132000
CY2020Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1202000
CY2021Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
771000
CY2020Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
840000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2482000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2756000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
70000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
125000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
263000
CY2021Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
488000
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
180819
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
281342000
CY2020Q4 sonx Temporary Equity Number Of Common Stock Equivalent Shares
TemporaryEquityNumberOfCommonStockEquivalentShares
17031887
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1914000
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
282198000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2372000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1644000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2372000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1644000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
12247000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.34
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.57
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2000000.0
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1300000
CY2021 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The Company leases office space under operating leases with expirations ranging from April 2022 to March 2025, some of which include rent escalations or an option to extend the lease for up to three years per renewal.
CY2021 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2021 us-gaap Lessee Operating Lease Lease Not Yet Commenced Description
LesseeOperatingLeaseLeaseNotYetCommencedDescription
the Company has not entered into any leases that have not yet commenced that would entitle the Company to significant rights or create additional obligations.
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1204000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1122000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1225000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1038000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
618000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
104000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2985000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
280000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2705000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
975000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1730000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M15D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0761
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
197000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
99000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
94000
CY2021 us-gaap Lease Cost
LeaseCost
1303000
CY2020 us-gaap Lease Cost
LeaseCost
1413000
CY2021 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
1206000
CY2020 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
1116000
CY2021 us-gaap Lease Cost
LeaseCost
1303000
CY2020 us-gaap Lease Cost
LeaseCost
1413000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
70731000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
60260000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
30000000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
30000000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
2000
CY2020 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
2000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0331
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0301
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0113
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0144
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2551
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2665
CY2021 sonx Effective Income Tax Rate Reconciliation Stock Based Compensation Percent
EffectiveIncomeTaxRateReconciliationStockBasedCompensationPercent
-0.0020
CY2020 sonx Effective Income Tax Rate Reconciliation Stock Based Compensation Percent
EffectiveIncomeTaxRateReconciliationStockBasedCompensationPercent
-0.0022
CY2021 sonx Effective Income Tax Rate Reconciliation Other Deferred Adjustments Percent
EffectiveIncomeTaxRateReconciliationOtherDeferredAdjustmentsPercent
0.0056
CY2020 sonx Effective Income Tax Rate Reconciliation Other Deferred Adjustments Percent
EffectiveIncomeTaxRateReconciliationOtherDeferredAdjustmentsPercent
0.0151
CY2021 sonx Effective Income Tax Rate Reconciliation Perm Items
EffectiveIncomeTaxRateReconciliationPermItems
-0.0029
CY2020 sonx Effective Income Tax Rate Reconciliation Perm Items
EffectiveIncomeTaxRateReconciliationPermItems
-0.0009
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2021Q4 sonx Deferred Tax Assets Fixed Assets And Intangible Assets
DeferredTaxAssetsFixedAssetsAndIntangibleAssets
1449000
CY2020Q4 sonx Deferred Tax Assets Fixed Assets And Intangible Assets
DeferredTaxAssetsFixedAssetsAndIntangibleAssets
1507000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
80538000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
1349000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
864000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
410000
CY2021Q4 sonx Deferred Tax Assets Tax Credits
DeferredTaxAssetsTaxCredits
4763000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
68549000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
79476000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
64211000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1062000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4338000
CY2021Q4 sonx Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
660000
CY2020Q4 sonx Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
783000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
1178000
CY2020Q4 sonx Deferred Tax Assets Tax Credits
DeferredTaxAssetsTaxCredits
4191000
CY2021Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
3000
CY2021Q4 sonx Deferred Tax Liabilities Fixed Assets And Intangible Assets
DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets
392000
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
670000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
890000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
49000
CY2020Q4 sonx Deferred Tax Liabilities Fixed Assets And Intangible Assets
DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets
605000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
4338000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
79500000
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
773000
CY2020Q4 sonx Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
2960000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1062000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
287600000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
245400000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
173400000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
145000000.0
CY2021Q4 sonx Deferred Tax Assets Operating Loss Carryforwards Will Not Expired
DeferredTaxAssetsOperatingLossCarryforwardsWillNotExpired
170500000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
3300000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
2900000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3900000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3400000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1800000
CY2021 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1575000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1311000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
204000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
251000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
12000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
13000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1791000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1575000
CY2021 us-gaap Revenues
Revenues
33197000
CY2020 us-gaap Revenues
Revenues
23351000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24861000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19466000
CY2021 us-gaap Gross Profit
GrossProfit
8336000
CY2020 us-gaap Gross Profit
GrossProfit
3885000
CY2021 sonx Gross Margin Percentage
GrossMarginPercentage
0.25
CY2020 sonx Gross Margin Percentage
GrossMarginPercentage
0.17
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33913000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26695000
CY2020 sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
-473000
CY2021 us-gaap Operating Expenses
OperatingExpenses
52742000
CY2020 us-gaap Operating Expenses
OperatingExpenses
46683000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-44406000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18568000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20461000
CY2021 sonx Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
261000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-42798000
CY2021 us-gaap Depreciation
Depreciation
1426000
CY2020 us-gaap Depreciation
Depreciation
2079000
CY2021Q4 us-gaap Assets
Assets
115499000
CY2020Q4 us-gaap Assets
Assets
76141000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-48499000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-46665000
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5694594
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1195944
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-8.52
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-39.02
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3789645
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19684684

Files In Submission

Name View Source Status
0000950170-22-004418-index-headers.html Edgar Link pending
0000950170-22-004418-index.html Edgar Link pending
0000950170-22-004418.txt Edgar Link pending
0000950170-22-004418-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img81637251_0.jpg Edgar Link pending
img81637251_1.jpg Edgar Link pending
img81637251_2.jpg Edgar Link pending
img81637251_3.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sonx-20211231.htm Edgar Link pending
sonx-20211231.xsd Edgar Link pending
sonx-20211231_cal.xml Edgar Link unprocessable
sonx-20211231_def.xml Edgar Link unprocessable
sonx-20211231_htm.xml Edgar Link completed
sonx-20211231_lab.xml Edgar Link unprocessable
sonx-20211231_pre.xml Edgar Link unprocessable
sonx-ex21_1.htm Edgar Link pending
sonx-ex23_1.htm Edgar Link pending
sonx-ex31_1.htm Edgar Link pending
sonx-ex31_2.htm Edgar Link pending
sonx-ex32_1.htm Edgar Link pending
sonx-ex32_2.htm Edgar Link pending
sonx-ex4_11.htm Edgar Link pending